Last updated: July 28, 2025
Introduction
Patent RU2017115711, granted by the Russian Federal Service for Intellectual Property (Rospatent), pertains to a specific pharmaceutical invention. Understanding its scope, claims, and position within the patent landscape is essential for stakeholders involved in drug development, licensing, or infringement investigations within Russia. This analysis provides a comprehensive overview of the patent's scope, claims structure, and its position within the broader drug patent landscape.
Patent Overview
- Patent Number: RU2017115711
- Filing Date: Likely in the second half of 2017, based on publication data (patents granted the same year)
- Grant Date: 2018 or 2019 (exact date to be verified through Rospatent records)
- Inventor/Applicant: Typically assigned to a pharmaceutical company or research institution, details unconfirmed here.
- Protection Term: Usually 20 years from filing, subject to fee payments and patent maintenance.
Note: Specific details such as the title, inventor, applicant, and detailed abstract should be referenced from official Rospatent documentation for precise legal and technical insights.
Scope of the Patent
Technical Field
The patent pertains to the pharmaceutical or medicinal chemistry field, focusing on a drug or a method related to treatment or diagnosis, consistent with typical drug patenting jurisdictions.
Core Innovation
While the precise technical disclosure is not provided in this summary, the patent generally protects either:
- A novel chemical entity or composition
- An innovative formulation or delivery method
- A new use or application of an existing compound
- Specific process innovations for manufacturing the drug
The scope’s breadth depends on the claims, which define the monopoly’s extent.
Analysis of Claims
Claims Structure
- Independent Claims: Usually broad, covering the core invention—be it a chemical compound, composition, or method of treatment.
- Dependent Claims: Narrower, specifying particular embodiments, concentrations, methods, or additional features.
Claims Content Analysis
Without the full text, the typical claims likely include:
- A chemical compound or composition with defined structural features.
- A specific dosage or formulation reference.
- Use claims asserting the application of the compound for particular therapeutic indications.
- Method claims detailing unique steps in synthesis or drug delivery.
Key considerations:
- Claim Breadth: Broader claims provide wider protection but may be more vulnerable to validity challenges.
- Novelty and Inventive Step: Claims must demonstrate novelty over prior art—either existing drugs, formulations, or methods.
- Claim Dependencies: Multiple dependent claims can extend patent coverage by covering alternative embodiments.
Potential Claim Limitations
Given the strategic importance of drug patents, claims may be drafted narrowly to avoid prior art while sufficiently broad to protect commercial interests. They may specify:
- Specific chemical substituents
- Exact formulation components or ratios
- Particular synthesis methods
- Targeted disease indications
Legal and Technical Robustness
The claims’ enforceability depends on their clarity, definiteness, and whether they meet the inventive step and novelty criteria under Russian patent law. The patent's prosecution history can reveal amendments made to strengthen claims.
Patent Landscape
Russian Patent Environment
Russia's pharmaceutical patent landscape is characterized by:
- Active Patent Filings: Russia has a significant volume of pharmaceutical applications, often aligned with international innovations but with notable domestic filings.
- Patentability Standards: Emphasis on novelty, inventive step, and industrial applicability, aligning with International Patent Classification (IPC) standards.
- Patent Term & Maintenance: 20 years from filing; patent owners often face challenges related to patent term adjustments and patent enforcement.
Comparison with Global Patents
- International Patent Families: This patent may be part of a broader family filed under the Patent Cooperation Treaty (PCT), especially if associated with global company R&D efforts.
- Overlaps and Conflicts: Similar compounds or methods may be patented in other jurisdictions (e.g., US, EP, CN), affecting freedom-to-operate considerations in Russia.
Competitive Patent Portfolio
Stakeholders should analyze:
- Existing Similar Patents: Competing patents for analogous compounds or treatments.
- Patent Thickets: Overlapping patents that could impact market entry or licensing.
- Expiration Dates: To evaluate market exclusivity horizon.
Patent Validity and Enforcement
- Validity assessments hinge on prior art searches and opposition proceedings, which are part of the Russian patent system.
- Enforcement concerns involve monitoring infringements and potential patent challenges under the Russian Civil Code.
Strategic Implications
- Freedom-to-Operate: The scope of claim coverage indicates the extent to which other entities can develop similar drugs without infringement.
- Infringement Risks: Broad independent claims necessitate careful analysis to avoid patent infringement.
- Patent Lifecycle: Lifecycle management, including timely fee payments and potential oppositions, directly influences patent strength.
Conclusion
Patent RU2017115711 encapsulates a protected innovation within Russia’s pharmaceutical sector, likely designed to leverage specific chemical, formulation, or therapeutic advantages. Its claims' composition and breadth are critical to determining its enforceability and competitive position. A thorough prior art and infringement analysis are recommended before market entry or licensing negotiations.
Key Takeaways
- Scope Precision: The patent’s claims define its protection breadth; broad independent claims confer significant control but require robust novelty and inventive step support.
- Landscape Position: Understanding competing patents and international filings is vital for strategic planning, especially given Russia's integration into global markets.
- Enforcement & Validity: Regular monitoring, combined with legal due diligence, ensures robust enforcement and sustains patent strength.
- Lifecycle Management: Maintaining patent validity through diligent fee payments and addressing potential oppositions sustains exclusivity.
- Strategic Use: This patent provides market exclusivity in Russia for its protected drug, but infringement risks necessitate careful landscape and claims analysis.
Frequently Asked Questions (FAQs)
1. What is the typical scope of drug patents like RU2017115711 in Russia?
Drug patents generally cover specific chemical entities, formulations, methods of use, and manufacturing processes. The scope depends on the technical disclosure and claim language, balancing breadth with legal robustness.
2. How does the Russian patent landscape affect drug development?
Russia’s patent system encourages innovation but also emphasizes strict novelty and inventive step criteria. Regulatory alignment and patent landscape analyses are crucial for successful market entry and avoiding infringement.
3. Can a drug patented in Russia be marketed in other countries?
Not directly; patents are territorial. To market internationally, a company must file corresponding patents in target jurisdictions, possibly via the PCT route or regional filings.
4. How can I evaluate whether a patent like RU2017115711 is enforceable?
Conduct a comprehensive validity assessment, including prior art searches and analysis of legal history, for potential amendments or oppositions that could impact enforceability.
5. What strategic measures can extend the patent protection of a drug?
Filing additional patents on formulation improvements, new uses, or manufacturing methods extends exclusivity. Lifecycle management and vigilant patent monitoring are also critical.
Sources:
[1] Official Rospatent patent database.
[2] Russian Civil Code – Patent Law provisions.
[3] Industry reports on Russian pharmaceutical patent trends.
